Closed call for evidence

Single dose of HPV vaccine: call for evidence from the JCVI

From:
Department of Health and Social Care
Published
18 March 2020
Last updated
16 April 2020 — See all updates
This was published under the 2019 to 2022 Johnson Conservative government

Summary

The JCVI is seeking evidence to inform possible changes to the HPV immunisation programme. We would like evidence around one-dose schedules for the HPV vaccine.

This call for evidence ran from
to

Call for evidence description

The Joint Committee on Vaccination and Immunisation (JCVI) is asking for evidence to support a review of possible changes to the human papillomavirus (HPV) immunisation programme.

JCVI is interested in relevant evidence to support consideration of the potential to move to a single-dose schedule of HPV vaccine for the routine programme and other alternative dose HPV schedules.

This call for evidence may be of particular interest to those who work in the field of HPV and immunisation, including:

  • academics
  • clinical researchers
  • clinicians
  • mathematical modellers
  • health economists
  • public health practitioners
  • sexual health
  • charities
  • implementation commissioning and delivery

  • the pharmaceutical industry

Documents

JCVI call for evidence: list of questions

HTML

Updates to this page

Published 18 March 2020
Last updated 16 April 2020 + show all updates

  1. The closing date for the call for evidence has been extended to 8 May 2020 to allow organisations more time to respond due to coronavirus (COVID-19).

  2. First published.

Sign up for emails or print this page

Related content